Journal of Nuclear Medicine October 2024, jnumed.124.268278; DOI: https://doi.org/10.2967/jnumed.124.268278 ...
Journal of Nuclear Medicine October 2024, jnumed.124.268363; DOI: https://doi.org/10.2967/jnumed.124.268363 metastatic castration-resistant prostate cancer prostate ...
Journal of Nuclear Medicine October 2024, jnumed.124.268036; DOI: https://doi.org/10.2967/jnumed.124.268036 ...
Journal of Nuclear Medicine October 2024, jnumed.124.268191; DOI: https://doi.org/10.2967/jnumed.124.268191 ...
Journal of Nuclear Medicine October 2024, jnumed.124.267948; DOI: https://doi.org/10.2967/jnumed.124.267948 ...
Journal of Nuclear Medicine October 2024, jnumed.124.268351; DOI: https://doi.org/10.2967/jnumed.124.268351 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine October 2024, jnumed.124.268292; DOI: https://doi.org/10.2967/jnumed.124.268292 ...
Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine October 2024, jnumed.124.267877; DOI: https://doi.org/10.2967/jnumed.124.267877 ...